Scientific Reference Database

Novel dual-agonist targeting both GLP-1 and GIP receptors to synergistically enhance metabolic signaling and optimize metabolic response to lipid intake.

Primarily observed for its impact on metabolic homeostasis, gastric emptying, and central satiety perception in rodent models.

Severe gastrointestinal motility inhibition, nausea, emesis, diarrhea, and hypoglycemia risk under caloric restriction.

Gastric pentadecapeptide that modulates the nitric oxide system and upregulates VEGFR2 receptors to facilitate angiogenesis and tissue remodeling.

Studied for gut mucosa stabilization, liver protection, and accelerating tendon/ligament healing.

Theoretical risk of promoting uncontrolled angiogenesis in undiagnosed pre-malignant cells.

CJC-1295 stimulates pituitary growth hormone secretion while Ipamorelin increases amplitude of pulses and suppresses somatostatin.

Used in endocrinology research to study natural pulse amplitude and frequency effects on metabolic health.

Fluid retention, edema, carpal tunnel-like symptoms, and elevated blood glucose levels.

Modified version of the HGH molecule (177-191) targeting lipolytic pathways without influencing insulin resistance or muscle hypertrophy.

Studied for targeted fat-mobilization efficacy without central nervous system stimulation.

Rapid influx of free fatty acids into the bloodstream, potentially affecting cardiovascular markers.

Coenzyme in mitochondrial cellular redox reactions. Essential for sirtuin activation, DNA repair, and longevity regulation.

Studied extensively in gerontology and mitochondrial health restoration research.

Rapid infusion causes intense flushing, severe nausea, or blood pressure fluctuations.

Synthetic version of Thymosin Beta-4 that sequesters G-actin, regulating actin filament polymerization and cell structural mobility.

Studied for potent tissue repair, cardiac cell regeneration, and anti-inflammatory properties.

Theoretical risk of facilitating metastasis of malignant cells due to cell migration promotion.

Tripeptide GHK with high affinity for copper, facilitating lysyl oxidase function for collagen and elastin cross-linking.

Used in skin, wound healing, and scar remodeling tissue studies.

Systemic copper toxicity leading to nausea, jaundice, and potential kidney/liver stress.

Tetrapeptide that upregulates telomerase expression, adding TTAGGG repeats to telomeres to delay cellular senescence.

Studied in biological age reversal, pineal gland regulation, and melatonin/cortisol balancing.

Theoretical risk of enabling indefinite replication of pre-malignant cells due to telomerase over-activation.

ACTH analog that stimulates brain production of BDNF and NGF without standard stimulant heart rate spikes.

Studied for cognitive enhancement, neuroprotection following ischemic injury, and focus enhancement.

Neuronal overstimulation leading to downstream brain fatigue.

Mitochondrial-derived peptide that activates the AMPK pathway, acting as a molecular exercise mimetic.

Studied for shifting cellular fuel utilization to fatty acid oxidation and improving insulin sensitivity.

Potential starvation of glucose-dependent cells, causing acute fatigue.

Melanocortin receptor agonist (MC3R/MC4R) that acts on hypothalamic neurons to stimulate libido and sexual response.

Studied for treatment of sexual dysfunction in animal and clinical models.

Acute nausea, headaches, and sudden elevated blood pressure.

Long-acting IGF-1 analog that avoids IGFBP binding, stimulating cellular hypertrophy and hyperplasia.

Researched for muscle wasting, tissue repair, and mitogenic division.

Severe hypoglycemia risk, organ enlargement (splenomegaly, cardiomegaly), and joint edema.

Tuftsin analog that stabilizes the GABAergic system and increases serotonin/dopamine expression.

Studied for anxiolytic action, cognitive clarity, and stabilization under stress.

Prolonged use can lead to receptor downregulation and emotional blunting.

Non-selective melanocortin receptor agonist stimulating skin tanning (MC1R) and sexual behavior pathways.

Studied for photoprotection and libido modulation.

Intense nausea, flushing, mole darkening, and skin cancer diagnostic risks.

Glu-Asp-Arg bioregulator peptide that protects neurons and stimulates hippocampal neurogenesis.

Investigated for cognitive function restoration and protection against oxidative stress.

Theoretical risk of altering neurological pathways due to excessive neuro-regeneration.

C-terminal region of HGH retaining lipolytic (fat-burning) domains without IGF-1 elevation or glucose impacts.

Studied for fat mobilization without Full-length HGH diabetogenic risks.

Local injection site pain or mild allergic reactions.

Neuropeptide modulating circadian rhythms, preparing brain for slow-wave deep sleep via GABA stabilization.

Investigated for sleep disorders, stress regulation, and endocrine balancing.

Paradoxical alertness in models, alterations in baseline pituitary output.

Long-acting GLP-1 receptor agonist that slows gastric emptying and stimulates glucose-dependent insulin secretion.

Standard benchmark molecule for appetite suppression and glycemic control research.

Nausea, vomiting, diarrhea, gallbladder stress, and risk of acute pancreatitis.

Triple agonist (GLP-1/GIP/Glucagon receptors) designed to maximize lipid mobilization while maintaining satiety.

Investigated for advanced weight loss percentages in metabolic dysfunction models.

Glucagon-induced glucose volatility, nausea, vomiting, and tachycardia.

Dual GLP-1 and Glucagon receptor agonist leveraging glucagon signaling to boost metabolic rate and burn liver fat.

Studied for steatotic liver disease (MASLD) and obesity pathology.

Glucagon-induced tachycardia and blood pressure spikes.

Synthetic amylin analog that suppresses glucagon secretion and acts on the area postrema to induce satiety.

Non-GLP-1-based satiety pathway weight management research.

Gastric emptying delay and stomach motility paralysis.

Balanced dual GLP-1 and Glucagon receptor agonist optimizing energy expenditure and caloric restriction.

Investigated for obesity and basal metabolic rate acceleration.

Tachycardia, palpitations, and intense gastrointestinal shifts.

Fixed-dose co-formulation of Cagrilintide (amylin analog) and Semaglutide (GLP-1 agonist).

REDEFINE clinical model studying synergistic dual-pathway satiety.

Profound muscle mass loss and severe nausea.

191-amino acid polypeptide stimulating cellular growth, division, and IGF-1 production.

Studied for tissue growth, lipid mobilization, and protein synthesis.

Insulin resistance, water retention, acromegaly, and joint edema.

Synthetic ghrelin mimetics binding to GHS-R to trigger endogenous GH release; GHRP-6 induces intense hunger.

Studied for pituitary amplitude pulses and metabolic recovery stimulation.

Elevated cortisol/prolactin, fluid retention, and gynecomastia.

GHRH analogs stimulating pituitary somatotrophs to secrete growth hormone.

Visceral fat reduction and age-related growth hormone regulation studies.

Joint pain and temporary alterations in glucose handling.

Potent GH secretagogue with high affinity for cardiac receptors, studied for cardioprotection.

Cardiovascular tissue protection and endocrine research.

Significant elevations in cortisol and prolactin.

HCG mimics LH; HMG delivers LH and FSH, stimulating gonadal steroidogenesis.

Reproductive endocrinology and post-cycle gonadotropin restoration studies.

Excessive conversion of testosterone to estradiol, causing gynecomastia and mood swings.

Thymus-derived peptides regulating T-cell maturation and innate immune coordination.

Immune function recovery and clinical antiviral models.

Theoretical induction of latent autoimmune responses.

LL37 handles antimicrobial defense; KPV acts as a potent local anti-inflammatory.

Gut integrity restoration and skin infection research.

LL37 causes severe local tissue irritation.

Mitochondria-targeted antioxidant protecting cardiolipin from oxidative damage.

Mitochondria protection in ischemia and cardiac recovery research.

Unknown long-term redox changes.

Muscle-specific IGF-1 splice variants stimulating satellite cell activation and local tissue repair.

Skeletal tissue repair and local cellular division research.

Cell proliferative signaling; high risk of accelerating growth of undiagnosed tumor cells.

Small molecule NNMT inhibitor that upregulates intracellular NAD+ and stimulates lipolysis.

Obesity, muscle wasting, and longevity research.

May alter global cellular methyl group availability.

Direct AMPK activator mimicking exercise, boosting fatty acid oxidation and glucose absorption.

Metabolic pathology and exercise performance mimicry research.

Intracellular lactic acid accumulation and cardiotoxicity risks.

Hypothalamic regulators stimulating GnRH and luteinizing hormone secretion.

HPTA axis signaling, reproductive fertility, and social behavior research.

HPTA shut-down and hormonal feedback crashes.